About the Fund
The Fund's investment strategy is sharply honed to target select industry sectors within the economy, leveraging deep-rooted insights and strategic foresight to capitalize on compelling growth opportunities.
The fund is a part of the r2p invest Group and MBA Consult. r2p invest Group is a significant player in the global investment market with a long-standing history. It actively invests in NPL portfolios across Latin America, Asia, and Europe.
MBA Consult specializes in NPL management and operates globally in this market. Collaborating closely with its strategic partner, MBA Consult, a licensed debt collection company, r2p invest Group has consistently demonstrated success in generating profits for its investors.
The Fund is structured as a single scheme fund, offering a focused investment approach tailored to meet the discerning needs of our investors.
At the heart of our operations lies effective Portfolio Management and Risk Management practices. Each investment decision is underpinned by exhaustive research, rigorous analysis, and a comprehensive understanding of market dynamics, thereby ensuring the preservation and enhancement of investor capital.
Credit Leasing
Credit Leasing represents a cornerstone of our strategic direction. This sector embodies a paradigm of financial innovation, offering a compelling avenue for generating consistent income streams while mitigating downside risks. Our strategic allocation towards credit leasing endeavors to capitalize on evolving consumer trends and emerging market dynamics, fostering resilience and diversification within our investment framework.
Bank Non-Performing Loans
Our strategic focus on Bank Non-Performing Loans (NPLs) underscores a commitment to proactive asset management and value realization, leveraging a disciplined approach to distressed debt investing to unlock latent value and drive superior risk-adjusted returns.
Healthcare
Our investments also target the healthcare sector, specifically focusing on medical services. We prioritize investments in companies and projects that enhance patient care delivery and address healthcare accessibility challenges. By concentrating on medical services, we aim to generate both financial returns and positive societal impact.
Our investment strategy revolves around a dynamic approach to equity participation in trade companies and the provision of strategic loans to businesses.
Anchored in prudence, agility, and value creation, our strategy seeks to unlock growth opportunities, foster entrepreneurship, and drive sustainable value for our investors and portfolio companies alike.
Thus, we combine the complementary strengths of equity participation and corporate lending, enabling us to capitalize on diverse opportunities, mitigate risk, and drive sustainable value creation across our investment portfolio. With a steadfast commitment to excellence, integrity, and investor-centricity, we remain dedicated to delivering superior investment outcomes and forging enduring partnerships with our stakeholders.
FAQ
Open-ended, investment company with variable capital, incorporated in Cyprus under the Companies Law Cap. 113, and authorised by the Cyprus Securities and Exchange Commission (CySEC) to operate as an Alternative Investment Fund addressed to a limited number of persons in accordance with Part VII of the AIF Law.
The Fund is established as a single scheme. The Fund is an Internally Managed Alternative Investment Fund with Limited Number of Persons in accordance with Section 125(1)(a) of the AIF Law.
We offer unique conditions for our investors:
- Fixed annual income of 6-10%
- Highly skilled professionals with extensive experience in the field of finance and investments
- High portfolio diversification, ensuring risk minimization and the opportunity to achieve greater profits.
We offer investment opportunities in the following projects:
Credit Leasing: Our primary focus lies in the Fund's investment strategy, particularly in Ta Meri Finance Pvt. Ltd. This company holds the distinction of being the first leasing company licensed by the Central Bank of Cyprus. Specializing in car financing, it offers a wide range of vehicles, catering to diverse preferences and budgets. From budget-friendly options to luxury models priced at €60,000 and above, Ta Meri Finance Pvt. Ltd. provides tailored financing solutions to meet varying client needs.
Healthcare: We also offer unique investment opportunities in the healthcare sector, with a specific emphasis on medical services. Our project, WeCare Medical Centre, sets a new standard in medical services, representing the first of its kind in Paphos. As a leading medical hub in Cyprus, WeCare integrates mobile technology into its operations, ensuring efficient and accessible healthcare services. In collaboration with the GeSY in Cyprus, it delivers primary care services to diverse demographics. Equipped with state-of-the-art laboratory facilities and staffed by qualified specialists across various fields, WeCare Medical Centre prioritizes excellence and innovation in healthcare delivery.
Minimum Initial Subscription Amount is €50,000 net.
Investors must maintain at least €25,000 invested in the fund until the lock-up period expires before they can redeem or withdraw their investment.
Investor must retain a minimum balance of €70,000. This requirement ensures that investors maintain a significant stake in the investment or fund even after partial withdrawals, which can help align their interests with the long-term performance and stability of the investment.
A professional investor with proven income.
Investors will receive dividends in the form of fixed monthly returns at a rate of 6% per annum. Investors also benefit from the expected appreciation of the Fund NAV upon redemption of their shares. 4% of the increase on the NAV is payable to participating investors.
Dividends are paid quarterly.
Minimum period is 2-3 years with the option to redeem earlier, under certain conditions.
The main information about the Fund is contained in the Fund Memorandum. You can review it by visiting the homepage of the website or by contacting us to request more detailed information
There are market risks, liquidity risks, inflationary, geopolitical, and others. Our fund closely monitors market conditions, portfolio status, and timely diversifies investments to avoid risky situations and loss of funds. We utilize various assets, invest in different industries, and employ geographical diversification. In this way, we prudently minimize losses for our investors, even if the situation is not entirely favorable.
Our portfolio manager constantly monitors the market situation. If circumstances arise that require an urgent change in the investment strategy, the Board of Directors convenes to make a decision.
The decision-making process looks like this:
- a Board of Directors’ resolution of the proposed changes;
- the prior approval of CySEC; This means that the draft amended Prospectus (with the amended investment strategy) shall be submitted to CySEC for approval;
- once approved by CySEC, the amended Prospectus is ratified by the Board of Directors;
- the approved by CySEC and the Board of Directors Prospectus is communicated immediately to existing participating investors.
Any changes to the Fund’s Investment Strategy shall first be approved by CySEC.
Zero exit payments subject to a 2-3-year share ownership period.
The process of redeeming or selling EUR Participating Shares before the scheduled Lock Up period expires provides for early redemption fee.